Maha Rashtra Apex Corporation Limited (MAHAPEXLTD.NS)
INR 161.8
(0.09%)
INR 161.8
(0.09%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 94.69 Million | 21.98 Million | 38.92 Million | 30.65 Million | 40.42 Million | 29.34 Million |
| Cost of Revenue | 31.24 Million | 23.59 Million | 21.83 Million | 18.57 Million | 29.87 Million | 29.47 Million |
| Gross Profit | 63.45 Million | -1.61 Million | 17.09 Million | 12.07 Million | 10.54 Million | -132 Thousand |
| Operating Expenses | 26.21 Million | 28.1 Million | -6.08 Million | -3.43 Million | 22.47 Million | -28.41 Million |
| Selling, General and Administrative Expenses | 26.21 Million | 8.61 Million | 5.68 Million | 3.44 Million | 8.47 Million | 8.22 Million |
| Research and Development Expenses | - | 0.59 | 0.80 | 1.27 | -0.15 | 1.17 |
| Other Expenses | - | 60.33 Million | 3.18 Million | 2.2 Million | 2.53 Million | 4.04 Million |
| Cost and Expenses | 26.21 Million | 51.69 Million | 15.74 Million | 15.14 Million | 52.35 Million | 1.05 Million |
| Operating Income | 68.48 Million | -41.38 Million | 880 Thousand | -1.45 Million | -11.88 Million | -22.82 Million |
| Interest Expense | - | 27 Thousand | 165 Thousand | 304 Thousand | 3.85 Million | 10.77 Million |
| Income Tax Expense | 15.15 Million | -1.69 Million | 5.84 Million | -15.82 Million | 121 Thousand | -345 Thousand |
| Earnings before Tax | 92.79 Million | 31.22 Million | 19.26 Million | 321.35 Million | 137.13 Million | 99.34 Million |
| Net Income | 3.46 Billion | 32.91 Million | 13.42 Million | 337.17 Million | 137.01 Million | 100.24 Million |
| Earnings Per Share Basic | 245.82 | 2.34 | 0.95 | 23.93 | 9.72 | 7.11 |
| Earnings Per Share Diluted | 245.82 | 2.34 | 0.95 | 23.93 | 9.72 | 7.11 |
| Weighted Average Shares Outstanding | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million |
| Gross Margin | 0.67 | -0.07 | 0.44 | 0.39 | 0.26 | -0.00 |
| EBIT Margin | 0.86 | -1.86 | 0.50 | 9.56 | 3.71 | 2.50 |
| Profit Margin | 36.58 | 1.50 | 0.34 | 11.00 | 3.39 | 3.42 |
| EBITDA | 81.63 Million | -29.31 Million | 19.79 Million | 321.98 Million | 141.28 Million | 59.77 Million |
| Earnings Before Tax Margin | 0.72 | -1.88 | 0.02 | -0.05 | -0.29 | -0.78 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 6.66 Million | 108.33 Million | 70.62 Million | 6.31 Million | 7.29 Million | 4.75 Million |
| Cost of Revenue | 163 Thousand | 15.95 Million | 5.12 Million | 5.99 Million | 5.15 Million | 5.03 Million |
| Gross Profit | 6.49 Million | 92.38 Million | 65.49 Million | 312 Thousand | 2.13 Million | -285 Thousand |
| Operating Expenses | 3.58 Million | 15.8 Million | 5.07 Million | 2.76 Million | 3.66 Million | 4.29 Million |
| Selling, General and Administrative Expenses | 6.78 Million | - | 7.44 Million | 5.94 Million | 5.11 Million | 5.03 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 1.32 Million | 23.95 Million | 1.84 Million | 1.29 Million | 13.96 Million | 4.09 Million |
| Cost and Expenses | 10.42 Million | 39.48 Million | 12.57 Million | 8.76 Million | 8.82 Million | 9.33 Million |
| Operating Income | -3.76 Million | 404 Thousand | 58.05 Million | -6.11 Million | -12.19 Million | -4.57 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -121.72 Million | 68.84 Million | 10.63 Million | 1000.00 | 4.52 Million | -4.57 Million |
| Earnings before Tax | -1.46 Million | 69.24 Million | 67.67 Million | -897 Million | 28.76 Million | 3.82 Million |
| Net Income | 120.25 Million | 92.79 Million | 4.35 Billion | -897 Million | 24.23 Million | 3.82 Million |
| Earnings Per Share Basic | 8.53 | - | 307.48 | -63.65 | 1.72 | 0.27 |
| Earnings Per Share Diluted | 8.53 | - | 307.48 | -63.65 | 1.72 | 0.27 |
| Weighted Average Shares Outstanding | 14.09 Million | 245.82 | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.09 Million | 245.82 | 14.09 Million | 14.09 Million | 14.09 Million | 14.09 Million |
| Gross Margin | 0.98 | 0.85 | 0.93 | 0.05 | 0.29 | -0.06 |
| EBIT Margin | -0.55 | - | 0.82 | -0.95 | -1.66 | -0.94 |
| Profit Margin | 18.06 | 0.86 | 61.64 | -142.13 | 3.32 | 0.80 |
| EBITDA | -3.66 Million | - | 58.15 Million | -6.01 Million | -12.09 Million | -4.47 Million |
| Earnings Before Tax Margin | -0.57 | 0.00 | 0.82 | -0.97 | -1.67 | -0.96 |
DRMA
6349
JOHNPHARMA
SLHN
TRIDENT
ASMVF